Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Arthritis Rheumatol. 2016 Mar;68(3):724–729. doi: 10.1002/art.39497

Figure 2. Characterization of antibody reactivity with different structural domains of TRIM21 and TRIM38.

Figure 2

Reactivity of sera from 3 different groups of pSjS patients (anti-TRIM38+ anti-TRIM21+, anti-TRIM38− anti-TRIM21+, anti-TRIM38− anti-TRIM21−) against different structural domains of TRIM21 (top panel) and TRIM38 (bottom panel) were evaluated in a quantitative immunoprecipitation assay. The data are presented as mean ΔCPM (CPM with antibody-CPM without antibody) + SD from 2 independent experiments.